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Natural products (NPs) have been a rich source of antibiotics and other pharmaceuticals. Unfortunately, discovery of structurally
novel and chemically tractable NPs has slowed down, resulting in decrease in industrial efforts NP discovery and development.
In this perspective, Roemer et al. discuss currently employed strategies for antifungal NP discovery and present potential solutions
for barriers in target identification and validation. The authors focus the discussion on a Candida albicans chemical genetics-based
NP screening approach and describe a dereplication strategy to predict the presence of known or new bioactive molecules within NP
extracts that might lead to resolution of issues that continue to disrupt NP-based antimicrobial discovery.AnEnzymatic Extender Unit GenerationMachine
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In vitro experiments using polyketide synthases (PKSs) are limited by the cost and
availability of extender units such as methylmalonyl-CoA. Hughes and Keatinge-
Clay show that the malonyl-CoA ligase Streptomyces coelicolor MatB can be
employed to help overcome this obstacle, synthesizing all combinations of five
diacids and three thiol acceptors. Methylmalonyl groups linked to CoA, D-pante-
theine, or N-acetylcysteamine were incorporated by a PKS module into a triketide
pyrone. Two MatB ternary complex structures provide structural insight into the
broad substrate specificity of this invaluable ligase. The research presented marks
significant progress towards the economical and preparative in vitro synthesis of
polyketides.c-Abl Activation through Myristoyl Binding Site
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Here, Yang et al. describe a small-molecule activator of the c-Abl kinase DPH, which was identified in an HTS campaign. DPH binds
to themyristoyl binding site of c-Abl and prevents the formation of its autoinhibited conformation. DPH displays potent enzymatic and
cellular activity in stimulating c-Abl activation, therefore representing the first cell-permeable, small-molecule tool compound for
c-Abl activation. It has been suggested that c-Abl activation may play a role in processes such as tumorigenesis, metastasis, and
normal myelopoiesis. Therefore, identification of this small-molecule c-Abl activator allows further investigation of the physiological
as well as pathophysiological functions of endogenous c-Abl.Flavonoid Metabolism Linked to Vacuolar
Trafficking Defects
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In this report, Rosado et al. assign two important functions to flavonoids: as metabolites
required for the maintenance of the vacuolar integrity under oxidative stress conditions
and as regulators of the delivery of vacuolar targeted cargoes. These characteristics
might be used to enhance or inhibit the accumulation of products of interest in the large
central vacuole either by genetic or chemical manipulation of the flavonoid biosynthetic
pathway. Further analysis of the Sortin1 chemical structure may provide useful informa-
tion regarding the Sortin1 binding partners and may also allow the uncoupling of vacuolar
cargo and flavonoids transport pathways. More broadly, the study demonstrates that
hypersensitive screens, forward and reverse genetics, and chemical genomics are
powerful tools to identify and dissect crosstalks between metabolic pathways.Primary and Secondary Metabolism Crosstalk
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The regulation of gene expression and product formation of the only PKS-NRPS present in the genome of the filamentous fungus
Aspergillus terreus has been elucidated. Although a transcriptional activator for PKS-NRPS expression was identified, induced over-
expression remained negatively dominated by glucose repression. Using b-galactosidase reporter strains, the natural conditions
required for gene activation and product formation were identified by Gressler et al., revealing a crosstalk of primary metabolism
through regulators such as CreA, PacC, and AreA with secondary metabolite production. The products are isoflavipucine and dihy-
droisoflavipucine, and isotope labeling experiments unveiled an unusual heterocycle rearrangement during metabolite biosynthesis.Chemistry & Biology 18, February 25, 2011 ª2011 Elsevier Ltd All rights reserved v
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DnaK is a molecular chaperone important for maintaining cellular proteostasis. The intrinsically slow ATPase activity of DnaK is stim-
ulated by its cochaperones, DnaJ andGrpE. To identify inhibitors of theDnaK-DnaJ combination, Chang et al. screened plant-derived
extracts against the reconstituted complex. These efforts led to the identification of flavonoids, including myricetin. Interestingly,
Chang et al. found that myricetin bound DnaK and prevented stimulation of ATP turnover by DnaJ, but that it had no effect on
DnaK alone or GrpE-DnaK. Based on results from NMR, computational simulations, and mutagenesis, myricetin appears to alloste-
rically interrupt the interaction betweenDnaJ andDnaK. Together, these results highlight the potential utility of a ‘‘gray box’’ screening
approach for targeting protein-protein interactions in complexes.vi Chemistry & Biology 18, FebruaryHalting the Glucose Transport
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The Warburg effect, in which glycolysis remains active even under aerobic conditions, is consid-
ered a key driver for cancer cell proliferation, malignancy, metastasis, and therapeutic resistance.
Currently, there is a limited arsenal of small molecules that can target aerobic glycolysis. Ulanov-
skaya et al. developed a new approach for rapid discovery of glycolytic inhibitors from structurally
diverse chemical libraries and successfully identified two chemical inhibitors of the GLUT family
of facilitative transmembrane transporters. Such compounds would be useful not only to study
the system-level organization of energy metabolism, but could also facilitate development of
drugs targeting upregulation of aerobic glycolysis in cancer.Correcting Trafficking Defect of F508del-CFTR by a Pharmacological
Chaperone
PAGE 231
Themost commonmutation causing cystic fibrosis (CF), F508del-CFTR, is retained in the endoplasmic reticulumand degraded rather
thanbeing trafficked to the cell surface,where it functions as a chloride channel.One therapeutic approach is to identify smallmolecule
pharmacological chaperones that bind directly to the F508del-CFTR protein and correct the trafficking defect. Sampson et al. use
differential scanning fluorimetry to identify a novel pharmacological chaperone, RDR1, which binds to the first nucleotide binding
domain (NBD1) of F508del-CFTR.RDR1partially correctsF508del-CFTR trafficking inmultiple cellmodels and in amousemodelofCF.
Sulfonylureas Are Isoform Selective Activators of Epac2
PAGE 243
Sulfonylureas (SUs), a common antidiabetes treatment, were recently identified as activators of exchange protein directly activated
by cAMP 2 (Epac2). Here, Herbst et al. investigate the underlying mechanisms of this molecular action and identify a key residue,
R447, to be critically involved in SU binding. SUs are further identified as isoform-selective activators of Epac2, as they do not acti-
vate the closely related Epac1. As Epac proteins emerge as key regulators of numerous cAMP-mediated signaling processes and as
new therapeutic targets, these findings should provide a basis for the development ofmore effective therapeutic agents and enhance
our fundamental understanding of Epac signaling.TGF-b Signaling Inhibitors via Profiling in Whole
Organisms
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Identifying small molecules with predictable in vivo efficacy remains a major challenge in drug
discovery. Dush et al. developed a novel phenotypic screen in frog embryos that revealed pyri-
dine derivativeswith highly desirable in vivo antitumor properties. Using a combination of inde-
pendent developmental phenotypes, immunohistochemical analyses, embryonic gene
expression patterns, and biochemical assays, the pyridine compounds were identified as
a new class of TGF-b signaling inhibitors. This work illustrates that multiphenotype profiling
in whole organisms is a powerful strategy for identifying bioactive small molecules and identi-
fying the pathway-level mechanism of action of novel compounds.
Inhibitors of the Uncoupling Proteins
PAGE 264
The uncoupling proteins (UCPs) are mitochondrial transporters that provide the cell with an energy dissipating mechanism used, for
example, to maintain body temperature. The UCPs also participate in the defense against oxidative stress and, thus, UCP2 plays
a protective role in tumor cells. Rial et al. have identified a series of chromane derivatives that inhibit the UCPs and demonstrated
that inhibition of UCP2 in HT-29 human carcinoma cells causes oxidative stress. The chromanes can act synergistically with chemo-
therapeutic agents increasing the efficacy of drugs such as arsenic trioxide. These findings open a promising line in the development
of novel anticancer agents.25, 2011 ª2011 Elsevier Ltd All rights reserved
